Clinical Trial Update: An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients [Phase 3]

View source ↗

Summary

Phase 3 trial investigating safety and efficacy of Replenine-VF in severe Haemophilia B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• Replenine®-VF (Factor IX concentrate)

Snippet

Sponsor: Bio Products Laboratory | Conditions: Haemophilia B | Phase 3 | Status: COMPLETED